retrovirus New Ano logo facebook_logo 1 twitter-logo retrovirus logo blue-paint-splatter blue-paint-splatter blue-paint-splatter blue-paint-splatter blue-paint-splatter blue-paint-splatter

Anovasia is a Singapore based company with a dedicated team of young entrepreneurs seeking windows of opportunity for its unique platform technology in the biotechnology industry through partnering and collaboration. Anovasia is implementing new ideas where they are most needed, using creativity and technology.

 

Anovasia uses its proprietary Molecular Painting platform to develop novel vaccine and drug delivery capabilities for licensing to partners. Safe and effective new vaccine vectors have already been shown to work in animal models. Immune cell-targeting and biological adjuvant technologies are in development.

Welcome to the Anovasia website

Molecular Painting describes the surface modification of any biological membrane such as cells, exosomes, enveloped viruses and liposomes. In contrast to other technologies, Molecular Paints are fully functional, natural biological molecules (proteins) which are manufactured using living cells. Molecular Painting provides the capability to quickly and easily add new biological functionality to existing or approved biomedical systems. As well as vaccine development and drug delivery, other applications include biomarker diagnostics, stem cells as well as cell and gene therapy.

 

In addition developing the core technology capabilities desribed above, Anovasia can act in a CRO capacity to design and produce tailor-made Molecular Painting reagents for partners and clients. For downstream clinical applications Anovasia can also provide fully cGMP qualified material.  

Pencil black small

Who are we?

What do we do?

Coming up

Meet with Anovasia's Co-Founder and Scientific Advisor Dr Brian Salmons at BIO International Convention in Boston USA from June 4th to 7th 2018.

 

 

 

 

 

See Timeline for recent past events

 

 

Anovasia news

In 2018 Anovasia team members publish real-time analysis of proteins acting in lipid bilayers.

 

Click here to go to our Publications page and get more details

 

 

See Timeline page for recently attended events and noteworthy news

Membrane modification

Cell membrane modification

Virus/viral membrane modification

Exosome membrane modification

Membrane vesicle modification

Membrane engineering

Biomembrane engineering

Molecular Painting

 

Membrane modification

Cell membrane modification

Virus/viral membrane modification

Exosome membrane modification

Membrane vesicle modification

Membrane engineering

Biomembrane engineering

Molecular Painting

 

Biomarker development

Vaccine development

Platform technology

Vector delivery

Vector targeting

scientists logo